
Improving care for young hearts
Imagine holding your newborn infant and hearing from your pediatrician that your child has a malformation of his or her heart, known as congenital heart disease (CHD). About 40,000 parents
Imagine holding your newborn infant and hearing from your pediatrician that your child has a malformation of his or her heart, known as congenital heart disease (CHD). About 40,000 parents
Margaret Hackett’s determination and resiliency in the face of several complex medical conditions is an inspiration to many. Together with her parents, Raynelle and Bill, she hopes to help others
Put simply, scientific research begins with a question, followed by a series of experiments, which—in some cases—eventually lead to a major discovery. Yet, how do these discoveries make their way
Since it became formally affiliated with the University of Chicago in 1958, the Chicago Home for Incurables has contributed more than $35 million to support medical research, with an emphasis
Each year in September, hundreds of sailors compete in the Chicago Regatta, an event that includes a variety of boat races off Chicago’s magnificent lakefront. Hosted by the Chicago Yacht
Richard Parrillo knows the University of Chicago Medicine better than most. He has been seeing his doctor, Mark Siegler, MD, for three decades, has undergone treatment for three types of cancer,
In 1982, in a suburban Chicago delivery room, Beverly and Jason Kravitt received devastating news. In rushed, unfeeling words, hospital staff told them that their infant son, Cameron, did not have a heartbeat. After giving birth to her stillborn son, Beverly was only allowed to hold him for a few minutes before he was whisked away.
The Robert B. Uretz, PhD, Memorial Awards provide financial support to students from backgrounds historically underrepresented in the sciences
The bequest will establish the Laurence B. Lewis Fund for Hematological Malignancies as a permanent fund within the University’s endowment.
The siblings made a $35,000 gift to support a bladder cancer clinical trial led by Dr. Peter O’Donnell.